Muzammil Mansuri

Muzammil M.
Mansuri is currently Chairman at Click Therapeutics, Inc. since 2021.
Holds director positions at Charm Therapeutics Ltd., Orsobio, Inc., and CHARM Therapeutics, Inc. Serves as Executive Director at Project Beacon Covid-19 LLC.
Venture Partner at F-Prime, Inc. since 2020.
Former roles include President & Chief Executive Officer at BIKAM Pharmaceuticals, Inc. Chairman & Chief Executive Officer at Gilead Connecticut, Inc. from 2007 to 2010.
Executive Chairman at Adaptive Therapeutics, Inc. Director-Central Chemistry at Bristol Myers Squibb Co. Director at Sequoia Pharmaceuticals, Inc., BG Medicine, Inc., and AVEO Pharmaceuticals, Inc. SVP-Research & Development Strategy at Gilead Sciences, Inc. from 2010 to 2016.
Executive VP-Strategy & Business Development at Sanofi.
Senior Advisor at JSB-Partners LP.
Chief Operating Officer & Executive Vice President at GPC Biotech, Inc. General Partner at Flagship Pioneering, Inc. from 2002 to 2007.
Research Scientist at Shell Research Ltd. Education includes doctorate degrees from The Trustees of Columbia University in The City of New York, the University of California, Los Angeles, and University College London, where an undergraduate degree was also earned.